Lexeo Therapeutics, Inc. (NASDAQ:LXEO) experienced a significant increase in share prices due to positive outlook on its treatment candidate, LX2020. Despite strong gains, the company reported widening losses. LXEO ranks 7th on a list of small firms with strong gains.